PON2 and early-onset autosomal dominant Alzheimer disease: The two reported PON2 polymorphisms associate with alterations of plasma lipid levels in patients affected by human diseases related to oxidative stress such as coronary artery disease (CAD) [31,32,33], type 2 diabetes mellitus, Alzheimer’s disease [34,35], and reduced bone mass in postmenopausal women [36].